BCL2 and colorectal cancer: We have shown that cytotoxic activity of a Wnt pathway inhibitor PP is more effective in combination with a pro-apoptotic Bcl-2 inhibitor (ABT737/ABT263) in killing colorectal cancer cells in vitro and in a xenografted human colon tumor in vivo (27).